Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections

BACKGROUND: Hepatitis C virus (HCV) genotype 6 (HCV-6) infection is prevalent predominantly in Southeast Asia, and the data on the virologic response of HCV-6 to direct-acting antivirals (DAAs) are sparse in people living with human immunodeficiency virus (HIV) (PLWH). AIM: To assess the virologic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hsin-Yun, Cheng, Chien-Yu, Lin, Chi-Ying, Yang, Chia-Jui, Lee, Nan-Yao, Liou, Bo-Huang, Tang, Hung-Jen, Liu, Yuang-Meng, Lee, Chun-Yuan, Chen, Tun-Chieh, Huang, Yi-Chia, Lee, Yuan-Ti, Tsai, Ming-Jui, Lu, Po-Liang, Tsai, Hung-Chin, Wang, Ning-Chi, Hung, Tung-Che, Cheng, Shu-Hsing, Hung, Chien-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985481/
https://www.ncbi.nlm.nih.gov/pubmed/35431505
http://dx.doi.org/10.3748/wjg.v28.i11.1172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985481/
https://www.ncbi.nlm.nih.gov/pubmed/35431505
http://dx.doi.org/10.3748/wjg.v28.i11.1172

Ejemplares similares